South Korea Hospital Acquired Infections Diagnostics Market Size & Outlook

The hospital acquired infections diagnostics market in South Korea is expected to reach a projected revenue of US$ 93.1 million by 2030. A compound annual growth rate of 1.5% is expected of South Korea hospital acquired infections diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$84.4
Forecast, 2030 (US$M)
$93.1
CAGR, 2025 - 2030
1.5%
Report Coverage
South Korea

South Korea hospital acquired infections diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea hospital acquired infections diagnostics market, 2018-2030 (US$M)

Related Markets

South Korea hospital acquired infections diagnostics market highlights

  • The South Korea hospital acquired infections diagnostics market generated a revenue of USD 84.4 million in 2024 and is expected to reach USD 93.1 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 1.6% from 2025 to 2030.
  • In terms of segment, conventional was the largest revenue generating test type in 2024.
  • Molecular is the most lucrative test type segment registering the fastest growth during the forecast period.


Hospital acquired infections diagnostics market data book summary

Market revenue in 2024USD 84.4 million
Market revenue in 2030USD 93.1 million
Growth rate1.6% (CAGR from 2025 to 2030)
Largest segmentConventional
Fastest growing segmentMolecular
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMolecular, Conventional
Key market players worldwideBioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc.


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.0% of the global hospital acquired infections diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China hospital acquired infections diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 199.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hospital Acquired Infections Diagnostics Market Companies

Name Profile # Employees HQ Website

South Korea hospital acquired infections diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.


Conventional was the largest segment with a revenue share of 54.38% in 2024. Horizon Databook has segmented the South Korea hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.


In South Korea, the market is highly competitive and technologically advanced, driven by a strong focus on innovation and high adoption of molecular diagnostics. Key players include global giants and local firms such as Seegene and SD Biosensor, which have pioneered innovations in multiplex molecular diagnostics. 

The South Korean market benefits from government-funded research initiatives that promote the development of HAI diagnostic tools, with a particular emphasis on solutions for antimicrobial resistance detection. 

South Korea has a robust regulatory system overseen by the Ministry of Food and Drug Safety (MFDS). The country has stringent guidelines for diagnostic device approval, with a clear pathway for clinical trials, post-market surveillance, and quality control. South Korea is proactive in addressing challenges such as antimicrobial resistance by fast-tracking innovative HAI diagnostic tools. 

Reasons to subscribe to South Korea hospital acquired infections diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea hospital acquired infections diagnostics market databook

  • Our clientele includes a mix of hospital acquired infections diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea Test Type - Hospital Acquired Infections Diagnostics Market size, 2024 - 2030 (US$M)

South Korea Hospital Acquired Infections Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

South Korea Test Type - Hospital Acquired Infections Diagnostics Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more